PTP — Pentixapharm Holding AG Income Statement
0.000.00%
Last trade - 00:00- €53.53m
- €48.91m
- €0.09m
Annual income statement for Pentixapharm Holding AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
R2024 December 31st | 2025 December 31st | |
|---|---|---|
| Period Length: | 41 W | 12 M |
| Source: | ARS | ARS |
| Standards: | IFRS | IFRS |
| Status: | Final | Final |
| Revenue | ||
| Total Revenue | 6.82 | 0.093 |
| Selling / General / Administrative Expenses | ||
| Depreciation and Amortization | ||
| Unusual Expense / Income | ||
| Other Operating Expenses | ||
| Total Operating Expenses | 23.8 | 20 |
| Operating Profit | -17 | -19.9 |
| Total Net Non Operating Interest Income / Expense | ||
| Net Income Before Taxes | -16.6 | -19.5 |
| Provision for Income Taxes | ||
| Net Income After Taxes | -11.9 | -16.5 |
| Net Income Before Extraordinary Items | ||
| Net Income | -11.9 | -16.5 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||
| Income Available to Common Shareholders Including Extraordinary Items | ||
| Diluted Net Income | -11.9 | -16.5 |
| Diluted Weighted Average Shares | ||
| Basic EPS Including Extraordinary Items | ||
| Diluted EPS Including Extraordinary Items | ||
| Diluted EPS Excluding Extraordinary Items | ||
| Normalised Income Before Taxes | ||
| Normalised Income After Taxes | ||
| Normalised Income Available to Common Shareholders | ||
| Diluted Normalised EPS | 0.179 | -0.647 |
| Dividends per Share |